300595.SZ
欧普康视
SZSE · Healthcare · C 制造业 · CN
CNY 10.71
−2.64%Year over year
Reported trailing growth
- Revenue
- +0.8%
- EBITDA
- —
- EBIT
- -9.0%
- EPS
- -13.7%
- Free cash flow
- +14.7%
- Operating cash flow
- -0.8%
Forward estimates
Based on analyst estimates
- Revenue
- +15.5%
- EBITDA
- +9.0%
- EPS
- +2.1%
Three-year CAGR
- Revenue
- +6.9%
- EBITDA
- -4.4%
- EBIT
- -6.6%
- Net income
- -8.4%
- EPS
- -9.2%
- Free cash flow
- +5.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026